These novel therapies, including Wegovy, a similar compound, and another option, represent a major advancement in addressing type 2 the condition and supporting weight management. They work by mimicking the body’s natural incretin GLP-1 , helping to regulate blood sugar and reduce appetite . The drug has somewhat distinct properties and can be ap